In the past few decades, numerous insights into the PI3K/Akt signaling pathway have revealed its complex networks, including its mechanism of activation, upstream and downstream targets, and types of inhibitors, thereby increasing our understanding of the occurrence and development of different types of human cancers. This evidence concerns the gene PIK3CA and cancer.